| Influenza coverage | Pneumococcal coverage | ||||||
---|---|---|---|---|---|---|---|---|
Initial analysis | Adjusted model a | Initial analysis | Adjusted model a | |||||
OR (95% CI) | p value | OR (95% CI) | p value | OR (95% CI) | p value | OR (95% CI) | p value | |
Latin America | ||||||||
 Chronic renal disease | 1.30 (0.96–1.77) | 0.089 | 1.38 (1.01–1.88) | 0.044 | 2.00 (1.44–2.77) | < 0.001 | 2.30 (1.63–3.35) | < 0.001 |
 Age > 50 years | 1.69 (1.22–2.35) | 0.001 | 1.70 (1.22–2.37) | 0.002 | 1.63 (1.15–2.32) | 0.006 | 1.67 (1.15–2.42) | 0.007 |
 Tetanus coverage | 2.24 (1.75–2.86) | < 0.001 | 2.25 (1.75–2.88) | < 0.001 | 3.62 (2.74–4.80) | < 0.001 | 3.79 (2.85–5.05) | < 0.001 |
Europe | ||||||||
 Chronic respiratory disease | NS d | NS d |  |  | 1.73 (1.18–2.56) | 0.006 | 1.86 (1.23–2.82) | < 0.001 |
 Smoking b | 0.57 (0.42–0.79) | 0.001 | 0.55 (0.39–0.76) | < 0.001 | 0.72 (0.52–1.01) | 0.058 | 0.67 (0.47–0.96) | 0.029 |
 Immunosuppressors c | 1.77 (1.27–2.47) | 0.001 | 1.97 (1.40–2.77) | < 0.001 | 1.71 (1.20–2.44) | 0.003 | 1.85 (1.27–2. 70) | < 0.001 |
 Age > 50 years | 2.16 (1.53–3.08) | < 0.001 | 2.37 (1.65–3.41) | < 0.001 | NS d | NS d |  |  |
 Tetanus coverage | 1.45 (1.08–1.93) | 0.012 | 1.54 (1.14–2.07) | 0.005 | 3.74 (2.72–5.14) | < 0.001 | 3.91 (2.83–5.40) | < 0.001 |